Skip to Main Content

3,153

Views

10

CrossRef citations to date

0

Altmetric

Research Paper

Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older

Ulrike K. Buchwalda Merck & Co., Inc., Kenilworth, NJ, USACorrespondence[email protected]

https://orcid.org/0000-0002-6671-0115 View further author information

,

Charles P. Andrewsb Diagnostics Research Group, San Antonio, TX, USAView further author information

,

John Ervinc Alliance for Multispecialty Research, Knoxville, TN, USAView further author information

,

James T. Petersond Foothill Family Clinic, Salt Lake City, UT, USAView further author information

,

Gretchen M. Tammsa Merck & Co., Inc., Kenilworth, NJ, USAView further author information

,

David Krupae IQVIA, Durham, NC, USAView further author information

,

Patrick Ajiboyee IQVIA, Durham, NC, USAView further author information

,

Lucy Roalfef University College London, London, UKView further author information

,

Andrea L. Kricka Merck & Co., Inc., Kenilworth, NJ, USAView further author information

,

Tina M. Sterlinga Merck & Co., Inc., Kenilworth, NJ, USAView further author information

,

Meihua Wanga Merck & Co., Inc., Kenilworth, NJ, USAView further author information

,

Jason C. Martina Merck & Co., Inc., Kenilworth, NJ, USAView further author information

,

Jon E. Steka Merck & Co., Inc., Kenilworth, NJ, USA

https://orcid.org/0000-0001-7521-874X View further author information

,

Melvin A. Kohna Merck & Co., Inc., Kenilworth, NJ, USAView further author information

,

Temitope Folaranmia Merck & Co., Inc., Kenilworth, NJ, USAView further author information

,

Chitrananda Abeygunawardanaa Merck & Co., Inc., Kenilworth, NJ, USAView further author information

,

Jonathan Hartzela Merck & Co., Inc., Kenilworth, NJ, USAView further author information

,

Luwy K. Museya Merck & Co., Inc., Kenilworth, NJ, USA

https://orcid.org/0000-0001-5484-7037 View further author information

& the V110–029 Study Group show all